Chemical Company of Malaysia Berhad (CCM)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Chemical Company of Malaysia Berhad (CCM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8012240
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月14日
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:マレーシア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Chemical Company of Malaysia Berhad (CCM) is an industrial and specialty chemicals company. Its core business activities include provision of pharmaceuticals and healthcare products; chemical products and applications; and polymer coatings and applications. The company’s product range find applications in a wide range of industries. CCM develops, manufactures and manufactures generic drugs and branded pharmaceutical products; provides water treatment solutions; and the polymer coating solutions for the rubber gloves industry. It also provides over-the-counter (OTC) brands such as CHAMPS, Diamelon, Donna, Flavettes and Proviton. The company has regional offices in Singapore, Indonesia and the Philippines. CCM is headquartered in Kuala Lumpur, Malaysia.

Chemical Company of Malaysia Berhad (CCM) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Chemical Company of Malaysia Berhad, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Chemical Company of Malaysia Berhad, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Chemical Company of Malaysia Berhad, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Chemical Company of Malaysia Berhad, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 8
Chemical Company of Malaysia Berhad, Pharmaceuticals & Healthcare, Deal Details 9
Equity Offering 9
Chemical Company of Malaysia to Raise USD15.79 Million in Private Placement of Shares 9
Acquisition 10
CCM Duopharma Biotech Acquires Six Pharma Units from Chemical Company of Malaysia for USD66.16 Million 10
Chemical Company Of Malaysia Acquires 11.6% Stake In PanGen Biotech 12
Chemical Company of Malaysia Berhad – Key Competitors 13
Chemical Company of Malaysia Berhad – Key Employees 14
Chemical Company of Malaysia Berhad – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Recent Developments 17
Strategy And Business Planning 17
Dec 07, 2016: CCM Sets up an Oncology Manufacturing Plant to Jumpstart Foray in Cancer Therapy 17
Financial Announcements 19
Aug 26, 2016: CCM’s Q2 Revenue Climbs 2.2 Per Cent To RM154.2 Million 19
Other Significant Developments 20
May 20, 2016: Perak Parkinson’s Association Takes Giant Steps To Build Coalition And Networks Globally To Promote Understanding And Treatment Of Parkinson’s 20
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Chemical Company of Malaysia Berhad, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Chemical Company of Malaysia Berhad, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 2
Chemical Company of Malaysia Berhad, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Chemical Company of Malaysia Berhad, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Chemical Company of Malaysia Berhad, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Chemical Company of Malaysia Berhad, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 8
Chemical Company of Malaysia to Raise USD15.79 Million in Private Placement of Shares 9
CCM Duopharma Biotech Acquires Six Pharma Units from Chemical Company of Malaysia for USD66.16 Million 10
Chemical Company Of Malaysia Acquires 11.6% Stake In PanGen Biotech 12
Chemical Company of Malaysia Berhad, Key Competitors 13
Chemical Company of Malaysia Berhad, Key Employees 14
Chemical Company of Malaysia Berhad, Subsidiaries 15

★海外企業調査レポート[Chemical Company of Malaysia Berhad (CCM)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Magyar Nemzeti Bank:企業の戦略的SWOT分析
    Magyar Nemzeti Bank - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Dorchester Minerals LP Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Dorchester Minerals LP Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Dorchester Minerals LP Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive info …
  • Gedeon Richter Plc:企業の戦略・SWOT・財務分析
    Gedeon Richter Plc - Strategy, SWOT and Corporate Finance Report Summary Gedeon Richter Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Innova Biosciences Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Innova Biosciences Ltd (Innova), a subsidiary of Sygnis AG is a provider of bioconjugation technologies and services. The company products include antibody labeling kits, antibody purification kits, affinity resins, gold nanoparticle kits, immunogen kits, rapid Ab labeling kits and others. I …
  • Topcon Corp (7732)-医療機器分野:企業M&A・提携分析
    Summary Topcon Corp (Topcon) is a medical device company that offers positioning and smart infrastructure and eye care products. The company provides positioning and smart infrastructure products which include TOCON and SOKKIA products. Topcon offers GNSS, total station, 3D scanner, machine control, …
  • NuVista Energy Ltd (NVA):企業の財務・戦略的SWOT分析
    Summary NuVista Energy Ltd (NuVista) is an oil and gas company that offers exploration, development and production of oil and natural gas reserves. The company conducts its operations in Western Canadian Sedimentary Basin which is located in West Central Alberta and Northeast British Columbia areas …
  • E&A Limited:企業の戦略・SWOT・財務情報
    E&A Limited - Strategy, SWOT and Corporate Finance Report Summary E&A Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • 7-Eleven Inc:石油・ガス:M&Aディール及び事業提携情報
    Summary 7-Eleven, Inc (7-Eleven) a subsidiary of Seven-Eleven Japan Co., Ltd., is a convenience store chain operator. The company operates through franchise and license models and offers a range of merchandises. It also operates as an independent gasoline retailer. The company’s store offers various …
  • DEME NV:電力:M&Aディール及び事業提携情報
    Summary DEME N.V. (DEME), a subsidiary of Compagnie d'Entreprises CFE SA is a dredging and hydraulic engineering services company. The company offers services, which include engineering solutions, installation of offshore wind farms, services to oil and gas companies, environmental activities such a …
  • CSI Compressco LP (CCLP):石油・ガス:M&Aディール及び事業提携情報
    Summary CSI Compressco LP (CSI), formerly Compressco Partners LP, a subsidiary of TETRA Technologies Inc, is an oilfield consulting company that offers compression services and equipment for natural gas and oil production, transportation, and storage. The company's products include real-time compres …
  • Ratchaburi Electricity Generating Holding Public Co Ltd (RATCH)-エネルギー分野:企業M&A・提携分析
    Summary Ratchaburi Electricity Generating Holding Public Company Limited (RATCH) is an independent power producer that invests in subsidiaries, associates and joint ventures which operate electricity generating and related businesses. The company operates independent power producing and small power …
  • Tokyo Printing Ink Mfg Co Ltd (4635)
    Tokyo Printing Ink Mfg Co Ltd (4635) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • BioTime Inc (BTX)-製薬・医療分野:企業M&A・提携分析
    Summary BioTime Inc (BioTime) is a biotechnology company which focuses on regenerative medicine and plasma volume expanders. The company’s Hextend is a blood plasma volume expander used for the treatment of hypovolemia in surgery, emergency trauma treatment, and other applications. It is also develo …
  • National Aluminium Co Ltd:企業の戦略・SWOT・財務情報
    National Aluminium Co Ltd - Strategy, SWOT and Corporate Finance Report Summary National Aluminium Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Libbs Farmaceutica Ltda-製薬・医療分野:企業M&A・提携分析
    Summary Libbs Farmaceutica Ltda (Libbs Farmaceutica) is a pharmaceutical company which offers biological drug products. The company offers monoclonal antibodies in various specialties which include cardiovascular, gynecology, oncology, dermatology, respiratory, and central nervous system transplant. …
  • GVK Biosciences Pvt Ltd-医療機器分野:企業M&A・提携分析
    Summary GVK Biosciences Pvt Ltd (GVK BIO) is a contract research organization that offers contract manufacturing and research services. The organization provides services such as discovery services, integrated programs, clinical development, contract manufacturing, formulations and informatics. It p …
  • PJSC Detsky Mir (DSKY):企業の財務・戦略的SWOT分析
    PJSC Detsky Mir (DSKY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Agfa HealthCare NV:医療機器:M&Aディール及び事業提携情報
    Summary Agfa HealthCare NV (Agfa HealthCare), a subsidiary of Agfa-Gevaert NV, is a healthcare information technology company, which provides eHealth and digital imaging solutions. It provides software for digital radiography, diagnostic imaging and healthcare IT solutions for hospitals and care cen …
  • Vyome Biosciences Pvt Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Vyome Biosciences Pvt Ltd (Vyome) is a clinical-stage biopharmaceutical company that develops novel drugs for antibiotic-resistant acne, other skin pathogens and anti-fungal agents in dermatology. The company’s pipeline products include VB 1953, VB 6345, VB 9333 and VB 9450. Its products are …
  • BSN medical GmbH:企業の戦略的SWOT分析
    BSN medical GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆